Associated Papers
IP-SNPs-seq links noncoding risk alleles to lineage transcription factor programs in prostate cancer.
Xu W et al.
Cellular and Molecular Life Sciences : Cmls, 2025
41359169 (PubMed )
Supplement: 18_2025_5964_MOESM5_ESM.xlsx › Figure_4e
FOXA1 regulates alternative splicing in prostate cancer.
Del Giudice M et al.
Cell Reports, 2022
36170835 (PubMed )
Supplement: mmc2.xlsx › primary_PC
Somatic driver mutation prevalence in 1844 prostate cancers identifies ZNRF3 loss as a predictor of metastatic relapse.
Fraser M et al.
Nature Communications, 2021
34716314 (PubMed )
Supplement: 41467_2021_26489_MOESM3_ESM.zip › Supplementary_Data › NatComms-Rev2-DataS06.xlsx › Driversv12-TableS11
Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer.
Xiao Q et al.
Scientific Reports, 2018
30150711 (PubMed )
Supplement: 41598_2018_30325_MOESM2_ESM.xlsx › SuppTable1-Sample_Group
Select a paper to view details